8 results  1 of 1 

1 Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
Min Ae Cho, Soo Young Jeong, Insuk Sohn, Myeong-Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Chel Hun Choi
Cancer Res Treat.2020;52(2):645-654.   Published online 2020 January 16     DOI: http://dx.doi.org/10.4143/crt.2019.509
      
2 Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway
Inho Kim, Chan Soon Park, Hae-Young Lee
Korean Circ J.2019;49(7):615-626.   Published online 2019 March 5     DOI: http://dx.doi.org/10.4070/kcj.2018.0379
      
3 Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
Da-Rae Kim, Joo-Hee Cho, Won-Seok Jang, Jin-Sug Kim, Kyung-Hwan Jeong, Tae-Won Lee, Chun-Gyoo Ihm
Electrolyte Blood Press.2013;11(2):56-59.   Published online 2013 December 31     DOI: http://dx.doi.org/10.5049/EBP.2013.11.2.56
      
4 Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis
Ho Jun Chin, Se Won Oh, Ho Suk Goo, Jieun Oh, Jung Woo Noh, Jong Tae Cho, Ki Young Na, Suhnggwon Kim, Dong-Wan Chae,
J Korean Med Sci.2011;26(1):59-66.   Published online 2010 December 22     DOI: http://dx.doi.org/10.3346/jkms.2011.26.1.59
      
5 Evaluation of Cardiac Function by Transthoracic Echocardiography in Subjects with ST-Segment Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention according to Valsartan Dose: The Valsartan One Center Trial
Sung-Sik Kim, Hui-Kyung Jeon, Gyu-Min Cho, Jong-Hwan Lee, Soo-Jung Kim, Mi-Youn Park, Seung-Jae Lee, Byung-Ju Shim, Dong-Hyeon Lee, Woo-Seung Shin, Jong-Min Lee, Ho-Joong Youn
J Cardiovasc Ultrasound.2010;18(3):77-83.   Published online 2010 September 30     DOI: http://dx.doi.org/10.4250/jcu.2010.18.3.77
      
6 Acute Renal Failure with Pulmonary Edema Induced by the Treatment of Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in a Patient with Congenital Solitary Kidney
Doo Hyun Baek, Kyung Jin Kim, Sung Chul Hong, Suk Hyung Kang, Ha Eung Song, Hye In Kim, Soo Hyun Kim, Hyun Jung Oh, Hye Won Kang, Seo Woo Kim, Min-A Yu, Dong-Ryeol Ryu, Kyu-Bok Choi, Duk-Hee Kang
Ewha Med J.2010;33(1):29-33.   Published online 2010 March 31     DOI: http://dx.doi.org/10.12771/emj.2010.33.1.29
      
7 The Effect of Telmisartan on Endothelial Function and Arterial Stiffness in Patients With Essential Hypertension
An Doc Jung, Weon Kim, Sang Hyun Park, Jeong Su Park, Sang Cheol Cho, Sung Bum Hong, Sun Ho Hwang, Wan Kim
Korean Circ J.2009;39(5):180-184.   Published online 2009 May 28     DOI: http://dx.doi.org/10.4070/kcj.2009.39.5.180
      
8 Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
Jeong-Hwan Park, Yong-Seog Oh, Ji-Hoon Kim, Woo-Baek Chung, Su-Sung Oh, Dong-Hyun Lee, Yun-Seok Choi, Woo-Seung Shin, Chul-Soo Park, Ho-Joong Youn, Wook-Sung Chung, Man-Young Lee, Ki-Bae Seung, Tae-Ho Rho, Jae-Hyung Kim, Soon-Jo Hong
Korean Circ J.2009;39(5):185-189.   Published online 2009 May 28     DOI: http://dx.doi.org/10.4070/kcj.2009.39.5.185
      

 1 of 1